Dry Eye Syndrome: Common Triggers and Risk Factors
The Rise of Prescription Anti-Inflammatory Drugs
While artificial tears provide symptomatic relief, prescription anti-inflammatory drugs are a rapidly growing segment of the Dry Eye Syndrome Market. This shift towards treating the underlying cause of dry eye is a key trend detailed in reports like the one on the Dry Eye Syndrome Market. Medications like Cyclosporine and Lifitegrast work by suppressing the chronic inflammation that often contributes to dry eye, helping to restore the eye's natural ability to produce tears. These drugs represent a major advancement from simple lubrication to a more therapeutic approach to managing the condition. The discussion could focus on the clinical benefits of this approach and the challenges of patient adherence to long-term medication.

